The UMass CFAR Clinical Core's mission is to provide the infrastructure and services that promoteinnovative patient-oriented and translational HIV research. The CFAR Clinical Core has the following goals:1) To facilitate interactions between basic scientists and clinical investigators that lead to patient-orientedstudies that improve our understanding of HIV pathogenesis and the development of novel prevention ortreatment strategies; 2) To provide the necessary expertise and services to facilitate patient-oriented andtranslational research; 3) To coordinate services with other CFAR Core Laboratories; 4) To support thetraining and advancement of new investigators in HIV-related research; and 5) To provide communityeducation regarding HIV and UMass CFAR Clinical HIV Research. The Clinical Core consists of a ClinicalSciences Core and a Clinical Immunology Core. The Clinical Sciences Core provides services that supportthe design, implementation, and analysis of patient-oriented and translational research with the goals ofstreamlining investigator training and protocol development. Other services provided by the ClinicalSciences Core include specimen receipt, processing, storage, and shipment; maintenance of extensive,integrated clinical (adult and pediatric) and laboratory databases; and a Bio-Statistics Sub-Core to providestatistical consultation for grant preparation, data analysis, and publications. The Clinical Immunology Coreprovides protocols, reagents, and services in support of patient-oriented and translational research. Inaddition, the UMass CFAR Clinical Core has recently partnered with the UMass Flow Cytometry Core todevelop a Biosafety Level 3 Flow Cytometry and Sorting Facility. Over the next funding period, the ClinicalCore will work with CFAR investigators and other CFAR Cores to provide services supporting studies thatimprove our understanding of HIV pathogenesis and strategies to prevent or treat HIV-1 infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI042845-10
Application #
7278940
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Project Start
2007-07-01
Project End
2012-06-30
Budget Start
2007-07-15
Budget End
2008-06-30
Support Year
10
Fiscal Year
2007
Total Cost
$328,312
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Gonzalez-Perez, Maria Paz; Peters, Paul J; O'Connell, Olivia et al. (2017) Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications. J Virol 91:
Ambade, Aditya; Satishchandran, Abhishek; Szabo, Gyongyi (2016) Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1? activation. Sci Rep 6:21340
Peters, Paul J; Gonzalez-Perez, Maria Paz; Musich, Thomas et al. (2015) Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes. Retrovirology 12:48
Fouda, Genevieve G; Cunningham, Coleen K; McFarland, Elizabeth J et al. (2015) Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses. J Infect Dis 211:508-17
Musich, Thomas; O'Connell, Olivia; Gonzalez-Perez, Maria Paz et al. (2015) HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages. Retrovirology 12:25
Gibson, Laura; Barysauskas, Constance M; McManus, Margaret et al. (2015) Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection. J Clin Immunol 35:289-301
Greenough, Thomas C; Straubhaar, Juerg R; Kamga, Larisa et al. (2015) A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV Infection. J Immunol 195:4185-97
Brehm, Michael A; Wiles, Michael V; Greiner, Dale L et al. (2014) Generation of improved humanized mouse models for human infectious diseases. J Immunol Methods 410:3-17
Luzuriaga, Katherine; Tabak, Barbara; Garber, Manuel et al. (2014) HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. J Infect Dis 210:1529-38
Fazly, Ahmed; Jain, Charu; Dehner, Amie C et al. (2013) Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis. Proc Natl Acad Sci U S A 110:13594-9

Showing the most recent 10 out of 122 publications